Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
Hagiwara N, Kawada-Watanabe E, Koyanagi R, Arashi H, Yamaguchi J, Nakao K, Tobaru T, Tanaka H, Oka T, Endoh Y, Saito K, Uchida T, Matsui K, Ogawa H. Hagiwara N, et al. Among authors: koyanagi r. Eur Heart J. 2017 Aug 1;38(29):2264-2276. doi: 10.1093/eurheartj/ehx162. Eur Heart J. 2017. PMID: 28430910 Free PMC article. Clinical Trial.
Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] substudy).
Sugiura R, Ogawa H, Oka T, Koyanagi R, Hagiwara N; HIJ-CREATE Investigators. Sugiura R, et al. Among authors: koyanagi r. Am J Cardiol. 2012 Feb 15;109(4):576-80. doi: 10.1016/j.amjcard.2011.09.050. Epub 2011 Nov 16. Am J Cardiol. 2012. PMID: 22100194 Clinical Trial.
Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E, Ogawa H, Koyanagi R, Arashi H, Yamaguchi J, Matsui K, Hagiwara N. Kawada-Watanabe E, et al. Among authors: koyanagi r. J Cardiol. 2017 Mar;69(3):536-541. doi: 10.1016/j.jjcc.2016.05.002. Epub 2016 Jun 24. J Cardiol. 2017. PMID: 27349705 Free article. Clinical Trial.
Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER.
Yamaguchi J, Kawada-Watanabe E, Koyanagi R, Arashi H, Sekiguchi H, Nakao K, Tobaru T, Tanaka H, Oka T, Endo Y, Saito K, Uchida T, Matsui K, Ogawa H, Hagiwara N. Yamaguchi J, et al. Among authors: koyanagi r. Atherosclerosis. 2018 Jul;274:139-145. doi: 10.1016/j.atherosclerosis.2018.04.036. Epub 2018 May 5. Atherosclerosis. 2018. PMID: 29772482
Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
Arashi H, Yamaguchi J, Kawada-Watanabe E, Koyanagi R, Sekiguchi H, Mori F, Haruta S, Ishii Y, Murasaki S, Suzuki K, Yamauchi T, Ogawa H, Hagiwara N. Arashi H, et al. Among authors: koyanagi r. J Am Heart Assoc. 2019 Aug 20;8(16):e012953. doi: 10.1161/JAHA.119.012953. Epub 2019 Aug 8. J Am Heart Assoc. 2019. PMID: 31390907 Free PMC article. Clinical Trial.
Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, Tsurumi Y, Koyanagi R, Kasanuki H; Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators. Shiga T, et al. Among authors: koyanagi r. Heart. 2009 Mar;95(3):216-20. doi: 10.1136/hrt.2008.145243. Epub 2008 Aug 26. Heart. 2009. PMID: 18728065
A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry.
Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, Yamaguchi J, Ishii Y, Fujii SY, Nagashima M, Okada H, Koganei H, Koyanagi R, Tsurumi Y, Kimura H, Ogawa H; HIJAMI Investigators. Kasanuki H, et al. Among authors: koyanagi r. Am Heart J. 2005 Sep;150(3):411-8. doi: 10.1016/j.ahj.2004.10.001. Am Heart J. 2005. PMID: 16169317
Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, Honda T, Haze K, Sumiyoshi T, Urashima M, Ogawa H; Heart Institute of Japan, Department of Cardiology (HIJC) Investigators. Nagashima M, et al. Among authors: koyanagi r. Am J Cardiol. 2007 Jun 1;99(11):1523-8. doi: 10.1016/j.amjcard.2007.01.024. Epub 2007 Apr 16. Am J Cardiol. 2007. PMID: 17531574
83 results